You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 10,295,534

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,295,534

Title:	Method for measuring anti-drug antibody
Abstract:	Provided is a method for measuring anti-drug antibodies ADAs appearing in a patient receiving molecular-targeted therapy in a simpler and more accurate manner.
Inventor(s):	Kashiwagi; Nobuhito (Takasaki, JP), Saitoh; Fumio (Takasaki, JP), Kaneda; Kenta (Takasaki, JP), Maegawa; Hidetaka (Takasaki, JP), Yagihashi; Yuko (Takasaki, JP)
Assignee:	JIMRO CO., LTD. (Takasaki-shi, JP)
Application Number:	15/498,930
Patent Claims:	1. A method for detecting anti-drug antibodies (ADAs) to a drug in an analyte, the method comprising: (1) providing a sample comprising an analyte to be measured for ADAs by adding the drug to the analyte to be measured for ADAs to yield a sample comprising drug-ADAs immune complexes; (2) after (1), contacting the sample with a carrier coated with complement Clq, anti-C3d antibody, or anti-Clq antibody to capture the drug-ADAs immune complexes; (3) after (2), washing the coated carrier to exclude free-form drug; (4) after (3), contacting a labeled or non-labeled antibody specific to the drug with the drug-ADAs immune complexes captured with the coated carrier; (5) after (4), washing the coated carrier to exclude unbound labeled or non-labeled antibody specific to the drug; and (6) after (5) detecting the drug-ADAs immune complexes binding to the complement Clq, anti-C3d antibody, or anti-Clq antibody with the labeled or non-labeled antibody specific to the drug by at least one immunoassay selected from the group consisting of enzyme immunoassay, chemiluminescence method, immunochromatography, plasmon resonance, fluorescence method, radioimmunoassay, immunoradiometric assay, fluorescence polarization immunoassay, immunonephelometry, latex agglutination turbidimetru, latex agglutination inhibition immunoassay, and time-resolved fluorescence immunoassay. 2. The method according to claim 1, wherein the drug added in (1) is in an amount sufficient to recover ADAs present in the analyate. 3. The method according to claim 1, wherein the drug is an anti-TNF.alpha. drug. 4. The method according to claim 3, wherein the drug is infliximab, adalimumab, golimumab, or certolizumab pegol. 5. The method according to claim 3, wherein the drug is infliximab or adalimumab. 6. The method according to claim 1, wherein the antibody in 4 is a labeled antibody. 7. The method according to claim 6, wherein the labeled antibody is an enzyme-labeled antibody. 8. The method according to claim 1, wherein the analyte to be measured is an analyte collected from a patient given the drug. 9. The method according to claim 1, wherein the contacting a labeled or non-labeled antibody to the drug with the coated carrier comprises contacting in the presence of calcium ion.

Details for Patent 10,295,534

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	08/24/1998	⤷ Try a Trial	2036-04-27
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	12/31/2002	⤷ Try a Trial	2036-04-27
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	02/21/2008	⤷ Try a Trial	2036-04-27
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	04/24/2013	⤷ Try a Trial	2036-04-27
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	09/23/2014	⤷ Try a Trial	2036-04-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.